Related Experiment Video
Updated: Sep 26, 2026

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors
Published on: July 17, 2020
Cutting edge: dependence of TCR antagonism on Src homology 2 domain-containing protein tyrosine phosphatase activity
Neely E Kilgore1, Jenny D Carter, Ulrike Lorenz
1Department of Microbiology and Immunology, Emory University, Atlanta, GA 30322, USA.
Abstract:
The mechanism by which antagonist peptides inhibit T cell responses is unknown. Mice deficient in Src homology 2 domain-containing protein tyrosine phosphatase (SHP-1) have revealed its importance in the negative regulation of lymphocyte signaling. We investigated a possible role for SHP-1 in T cell antagonism and demonstrate, for the first time, a substantial increase in SHP-1 activity during antagonism of CD4(+) T cells. Furthermore, the removal of functional SHP-1 prevents antagonism in these cells. Our data demonstrate that T cell antagonism occurs via a negative intracellular signal that is mediated by SHP-1.
Insights
Antagonist peptides inhibit T cell responses through a newly identified mechanism involving Src homology 2 domain-containing protein tyrosine phosphatase (SHP-1). Increased SHP-1 activity is crucial for this T cell antagonism.
Area of Science:
- Immunology
- Molecular Biology
- Cell Signaling
Background:
- The precise mechanism by which antagonist peptides inhibit T cell responses remains unclear.
- Src homology 2 domain-containing protein tyrosine phosphatase (SHP-1) is known to be vital for the negative regulation of lymphocyte signaling.
Purpose of the Study:
- To investigate the potential role of SHP-1 in the process of T cell antagonism.
- To elucidate the molecular underpinnings of T cell response inhibition by antagonist peptides.
Main Methods:
- Utilized mice deficient in SHP-1 to assess its function in T cell signaling.
- Measured SHP-1 activity in CD4(+) T cells during antagonism.
- Assessed the effect of removing functional SHP-1 on T cell antagonism.
Main Results:
- Demonstrated a significant increase in SHP-1 activity during the antagonism of CD4(+) T cells.
- Showed that the absence of functional SHP-1 abrogates the antagonistic effect on these T cells.
Conclusions:
- T cell antagonism is mediated by a negative intracellular signal.
- This negative signaling pathway is dependent on the activity of SHP-1.
Related Concept Videos
Receptor Tyrosine Kinases
Enzyme-linked Receptors
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Conservation of Protein Domains Over Different Proteins
A limited set of protein domains often duplicate and recombine during evolution. These domains can be organized in different combinations to form...
TGF - β Signaling Pathway

